D-0042-2021 Class III Terminated

Recalled by eVenus Pharmaceutical Laboratories — Princeton, NJ

FDA drug recall D-0042-2021 was initiated by eVenus Pharmaceutical Laboratories on Oct 6, 2020 and is designated Class III. Reason for recall: DEFECTIVE CONTAINER: Desflurane Liquid for Inhalation 240 mL may be leaking. The recall status is terminated (terminated May 19, 2022). Affected quantity: 9210 units.

Recall details

Product Type
Drugs
Report Date
Oct 28, 2020
Initiation Date
Oct 6, 2020
Termination Date
May 19, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9210 units

Product description

Desflurane, USP Liquid for Inhalation, 240 mL, Rx Only, Manufactured by: Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, 200245, China for Sandoz Inc. Princeton, NJ 08540, NDC 0781-6172-22

Reason for recall

DEFECTIVE CONTAINER: Desflurane Liquid for Inhalation 240 mL may be leaking.

Distribution pattern

CO only

Code information

Lot #: 20011831, Exp. Date 12/2021; 20041431, Exp. Date 03/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0042-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0042-2021. Report a data issue: hello@regdatalab.com.